Matinas Biopharma Holdings Net Income 2012-2018 | MTNB

Matinas Biopharma Holdings net income from 2012 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Matinas Biopharma Holdings Annual Net Income
(Millions of US $)
2017 $-33
2016 $-12
2015 $-9
2014 $-10
2013 $-4
2012 $-0
2011 $0
Matinas Biopharma Holdings Quarterly Net Income
(Millions of US $)
Q3 2018 $-3
Q2 2018 $-4
Q1 2018 $-4
Q4 2017 $-4
Q3 2017 $-4
Q2 2017 $-4
Q1 2017 $-21
Q4 2016 $-2
Q3 2016 $-6
Q2 2016 $-2
Q1 2016 $-2
Q4 2015 $-2
Q3 2015 $-2
Q2 2015 $-2
Q1 2015 $-3
Q4 2014 $-3
Q3 2014 $-3
Q2 2014 $-2
Q1 2014 $-2
Q4 2013 $-2
Q3 2013 $-1
Q2 2013 $-0
Q1 2013 $-0
Q4 2012 $0
Q3 2012 $0
Q4 2011 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.137B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.705B 31.73
Takeda Pharmaceutical (TAK) Japan $33.622B 12.44
Grifols (GRFS) Spain $13.132B 15.92
Ionis Pharmaceuticals (IONS) United States $11.141B 34.55
Neurocrine Biosciences (NBIX) United States $8.158B 528.41
Jazz Pharmaceuticals (JAZZ) Ireland $7.761B 11.11
Sage Therapeutics (SAGE) United States $7.440B 0.00
Tilray (TLRY) United States $6.545B 0.00
Catalent (CTLT) United States $6.280B 26.29
Nektar Therapeutics (NKTR) United States $5.829B 9.30
United Therapeutics (UTHR) United States $5.377B 9.14
FibroGen (FGEN) United States $4.759B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.340B 23.06
Taro Pharmaceutical Industries (TARO) Israel $4.251B 13.68
PTC Therapeutics (PTCT) United States $2.297B 0.00
Zogenix (ZGNX) United States $2.294B 0.00
Portola Pharmaceuticals (PTLA) United States $2.247B 0.00
Aerie Pharmaceuticals (AERI) United States $2.239B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.213B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.182B 0.00
USANA Health Sciences (USNA) United States $2.061B 17.30
Endo (ENDP) Ireland $1.966B 3.03
Enanta Pharmaceuticals (ENTA) United States $1.938B 24.13
Heron Therapeutics (HRTX) United States $1.926B 0.00
Xencor (XNCR) United States $1.807B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.639B 141.96
Theravance Biopharma (TBPH) Cayman Islands $1.374B 0.00
Corcept Therapeutics (CORT) United States $1.357B 19.72
TherapeuticsMD (TXMD) United States $1.312B 0.00
Esperion Therapeutics (ESPR) United States $1.186B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.134B 0.00
Tricida (TCDA) United States $1.069B 0.00
Radius Health (RDUS) United States $0.884B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.870B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.617B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.598B 0.00
Dermira (DERM) United States $0.577B 0.00
Collegium Pharmaceutical (COLL) United States $0.567B 0.00
GlycoMimetics (GLYC) United States $0.566B 0.00
Odonate Therapeutics (ODT) United States $0.565B 0.00
ArQule (ARQL) United States $0.560B 0.00
Forty Seven (FTSV) United States $0.551B 0.00
ChemoCentryx (CCXI) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.496B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.495B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.493B 29.09
Siga Technologies (SIGA) United States $0.485B 0.00
KalVista Pharmaceuticals (KALV) United States $0.484B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
Translate Bio (TBIO) United States $0.448B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.443B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 0.00
Concert Pharmaceuticals (CNCE) United States $0.413B 0.00
OptiNose (OPTN) United States $0.391B 0.00
ImmunoGen (IMGN) United States $0.384B 0.00
Aptorum Group (APM) China $0.380B 0.00
Karyopharm Therapeutics (KPTI) United States $0.354B 0.00
Minerva Neurosciences (NERV) United States $0.324B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.310B 11.50
Lannett Co Inc (LCI) United States $0.302B 2.81
Majesco Entertainment (PTE) United States $0.287B 0.00
Mast Therapeutics (SVRA) United States $0.284B 0.00
Immune Design (IMDZ) United States $0.282B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.278B 0.00
Xeris Pharmaceuticals (XERS) United States $0.271B 0.00
Dova Pharmaceuticals (DOVA) United States $0.264B 0.00
Affimed (AFMD) Germany $0.261B 0.00
HARPOON THERAPT (HARP) United States $0.260B 0.00
Aclaris Therapeutics (ACRS) United States $0.259B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.256B 0.00
ElectroCore (ECOR) United States $0.254B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Tyme Technologies (TYME) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.220B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.216B 0.00
Jounce Therapeutics (JNCE) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.214B 0.00
Recro Pharma (REPH) United States $0.211B 0.00
Molecular Templates (MTEM) United States $0.211B 0.00
Aldeyra Therapeutics (ALDX) United States $0.208B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
IMV INC (IMV) Canada $0.202B 0.00
Rafael Holdings (RFL) United States $0.195B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.192B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.191B 0.00
Redhill Biopharma (RDHL) Israel $0.188B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.188B 0.00
Aratana Therapeutics (PETX) United States $0.188B 0.00
Ocular Therapeutix (OCUL) United States $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.40
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neos Therapeutics (NEOS) United States $0.166B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.164B 0.00
Neon Therapeutics (NTGN) United States $0.156B 0.00
AgeX Therapeutics (AGE) United States $0.150B 0.00
ProNAi Therapeutics (SRRA) Canada $0.142B 0.00
MediWound (MDWD) Israel $0.140B 0.00
China SXT Pharmaceuticals (SXTC) China $0.138B 0.00
Cardiome Pharma (CORV) Canada $0.121B 0.00
Champions Oncology (CSBR) United States $0.121B 0.00
DURECT (DRRX) United States $0.119B 0.00
Zafgen (ZFGN) United States $0.112B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.111B 0.00
Adherex Technologies (FENC) United States $0.107B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.107B 0.00
Iterum Therapeutics (ITRM) Ireland $0.106B 0.00
Infinity Pharmaceuticals (INFI) United States $0.098B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.089B 0.00
Avenue Therapeutics (ATXI) United States $0.088B 0.00
Natural Alternatives (NAII) United States $0.084B 8.24
Genocea Biosciences (GNCA) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.079B 0.00
India Globalization Capital (IGC) United States $0.078B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.070B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.067B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.065B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.061B 0.00
Forward Pharma (FWP) Denmark $0.059B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.058B 0.00
CTI BioPharma (CTIC) United States $0.057B 0.00
KemPharm (KMPH) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Melinta Therapeutics (MLNT) United States $0.048B 0.00
Bio-Path Holdings (BPTH) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
NOVAN INC (NOVN) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
ContraFect (CFRX) United States $0.037B 0.00
HANCOCK JAFFE (HJLI) United States $0.035B 0.00
Achaogen (AKAO) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
Shineco (TYHT) China $0.026B 4.42
Summit Therapeutics (SMMT) United Kingdom $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.026B 0.00
IsoRay (ISR) United States $0.025B 0.00
Biomerica (BMRA) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
VAXART, INC (VXRT) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00